Neutralizing antibodies for the prevention and treatment of COVID-19

L Du, Y Yang, X Zhang - Cellular & molecular immunology, 2021 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) initiates the infection
process by binding to the viral cellular receptor angiotensin-converting enzyme 2 through …

Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis

E Karakike, EJ Giamarellos-Bourboulis… - Critical care …, 2021 - journals.lww.com
Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing
respiratory tract infection, which can induce respiratory failure and multiple organ …

Neutrophils and COVID-19: active participants and rational therapeutic targets

J Hazeldine, JM Lord - Frontiers in immunology, 2021 - frontiersin.org
Whilst the majority of individuals infected with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the causative pathogen of COVID-19, experience mild to …

Predictors of the severity of the course of COVID-19: Demographic factors, clinical signs and laboratory markers

K Bartoszewicz, M Bartoszewicz… - Journal of Medical …, 2024 - microbiologyresearch.org
Introduction. The Coronavirus Disease 2019 (COVID-19) pandemic has had a significant
impact on global healthcare, with high mortality and severe complications remaining a major …

COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU

J Pluta, A Cieniewicz, J Trzebicki - Anaesthesiology Intensive Therapy, 2021 - termedia.pl
Patients hospitalized in the intensive care unit (ICU) due to the COVID-19 experience a high
incidence (up to 43%) of venous thromboembolic events. While laboratory findings in COVID …

The impact of bacterial superinfections on the outcome of critically ill patients with COVID-19 associated acute respiratory distress syndrome (ARDS)–a single-centre …

J Sysiak-Sławecka, O Wichowska… - Anaesthesiology …, 2023 - termedia.pl
Results: We did not find a difference in the number of superinfections between the ECMO
and CON groups (11 vs. 10, P= 1.0). The mortality rate was 67% in the ECMO group and …

Recent Advance Analysis of Recovery in Hospitalized People with COVID-19: A Systematic Review

JNV Santos, VA Mendonca, AC Fernandes… - International Journal of …, 2022 - mdpi.com
Introduction: COVID-19 is a public health emergency all around the world. Severe illness
occurred in about 14% of patients and 5% of patients developed critical illness, but the …

Treatment outcomes in Polish COVID-19 patients requiring hospitalisation in the intensive care unit: a single-centre retrospective study

M Mikiewicz, K Polok, P Somionka, J Krzywoń… - Anaesthesiology …, 2022 - termedia.pl
Results We enrolled 108 patients at a mean age of 64.3 (SD= 12) years, the majority of
whom were male (63.9%). Mortality in the ICU, after 30 days and 90 days was …

Nutritional management in critically ill patients with COVID-19: a retrospective multicentre study

JK Danel, M Taborek, A Nowotarska… - Anaesthesiology …, 2024 - termedia.pl
Results: Evaluation of nutritional therapy was performed in 129 subjects. The fulfilment of
caloric requirement considering the HB, MsJ and ESPEN formula was 66%, 66.7% and …

COVID-19: zaburzenia krzepnięcia i leczenie przeciwzakrzepowe u pacjentów hospitalizowanych na oddziale intensywnej terapii

J Pluta, A Cieniewicz, J Trzebicki - Anestezjologia Intensywna Terapia, 2021 - termedia.pl
Patients hospitalized in the intensive care unit (ICU) due to the COVID-19 experience a high
incidence (up to 43%) of venous thromboembolic events. While laboratory findings in COVID …